A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Taiho Oncology, Inc.
Taiho Oncology, Inc.
National Cancer Institute (NCI)
Center for International Blood and Marrow Transplant Research
Memorial Sloan Kettering Cancer Center
Masonic Cancer Center, University of Minnesota
Ossium Health, Inc.
M.D. Anderson Cancer Center
Apollo Therapeutics Ltd
First Affiliated Hospital of Zhejiang University
Institute of Hematology & Blood Diseases Hospital, China
Ohio State University Comprehensive Cancer Center
Fred Hutchinson Cancer Center
ARCE Therapeutics, Inc.
Children's Hospital Medical Center, Cincinnati
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
The University of Hong Kong
Medical College of Wisconsin
Children's Hospital of Philadelphia
Istituto Clinico Humanitas
European Institute of Oncology
Rigshospitalet, Denmark
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine